Theranos whistleblower: How to prevent another $600M Silicon Valley disaster

Even now, Erika Cheung can get a little nervous about being followed.

The occasional unease is the lingering aftereffect of the former Theranos lab associate’s role in exposing the now-defunct health-care startup, which shuttered last year after whistleblowers and journalists uncovered its dubious blood-testing practices.

Wall Street Journal reporter John Carreyrou broke the story in 2015 that the then-Silicon Valley darling did not have the technology to carry out a range of important tests on just a thimble-sized vial of blood. An array of public figures and international business tycoons had invested a collective $600 million in the failed venture.

>>> Original Source <<<